Member Info for LordSnooty

the Puce Predictor is, sadly out of commission. The Mark II version was trodden on last night by Her Ladyship as she made her way to the commode at 4am. Such are the vagaries of female plumbing in the midlife.

appalling RNS. An extract: Despite bullish assertions to the contrary from some extraterrestrials on this thread, "As previously announced, the pilot plant is not able to recover diamonds with dimensions bigger than 25mm and 10 larger carat stones have been broken during recovery with an estimated loss of revenue to the Company of between approximately US$15-25 million. The Board is currently considering when the operation of the pilot plant should be discontinued in preparation of the mine site for the Expansion Project but envisages it to be before the end of the calendar year. A portion of the Placing proceeds will be used to fund the operational cost of the pilot plant until its closure." Another gem, "The market conditions in the mining industry are currently very challenging and the diamond industry is no exception. These conditions are particularly difficult for the junior mining sector...." Again, "Board considering timing to discontinue the Group's Pilot Plant at Liqhobong, currently envisaged before the end of the calendar year, in preparation for the main treatment plant ("MTP") minesite development". Yet more, "A further substantial equity fundraise will be required to fund the MTP but the Company is pursuing a number of additional funding alternatives to try and minimise the equity dilution for Shareholders." Yeah, right! So no revenue for two years while P2 is being installed - IF someone is mug enough to stump up the cash.

at 7 just bought.

I wouldn't trust the buy and sell trades on a stock like XEN further than I could throw them - as I said, I believe they are mostly disguised MM nonsense, and that the true situation is there that there is very little free float.

it's mostly smoke and mirrors, I think; I don't believe there are suddenly half a million shares in the float, after days of no trades.

30k

about to happen

Looks to me like MM-generated churning, so far no movement in the sp....

I sympathise but the writing has been on the wall plain to see for many many months now, and only apologists for the directors, who still take home lavish salaries and bonuses, still have forlorn hope, against all evidence to the contrary, for this slow-motion disaster. You have very little left to lose by hanging on, but I certainly would not advise putting any more money in to average down; many people have made that mistake all the way down and regretted it in a classic case of throwing good money after bad. What a joke that they now have to raise "only" $140m.

The only surprise is that this didn't happen earlier. Consistently poor sales at auction and continuing losses made this inevitable. PIs will be diluted out of existence before the directors and their fat salaries are done. Raise US$170m? You must be joking.

Behind every successful man, there is a woman. Behind every dead man, there is Jimmy.

I've finally seen off that gaolbird Leeson...

there is a need here, while we wait, for some leadership on this thread, to put some backbone in the rank and file. Snooty is the man for the job: a long family history of generalship in adverse circumstances, including many magnificent retreats, admirals that went down with their ships and archbishops burned mute at the stake gives Snooty those qualities of leadership that get the job done. Why, in one's scout troop. who had the most badges? So I say to you, brave Xenopeople, the motto, escutcheoned on the Snooty coat of arms for eternity "Arse longa, vita brevis"!

It's a function of the illiquidity of XEN, and fortunately it works on the upside as well as the downside. It only takes a seller of 150k shares to drop the stock 8% in the absence of any supporting news, as we saw the other day. But remember that the sp nearly tripled in short order back in January, on the back of Big Pharma news that never materialised because of due diligence requirements. I'm very confident there is a lot going on behind the scenes which will shortly put paid to these levels permanently. The wonder is that there appears to be only an average of one buyer a day who recognises the fact.

mention Snooty? One has a brace of Purdeys filed away in the drinks cabinet....

It was results of PSA-EPO out of India. It was also in an AIM market that actually had some buyers.

CEO of Xenetic Biosciences said: “We are delighted to welcome a person of Rob’s calibre to our Boston team where he will be instrumental in developing the Xenetic’s US visibility with the banking and investment community. We now have two very senior people from Big Bio (and the world’s two leading orphan drug players) as part of our Boston management team. This Big Bio experience is invaluable in our drive to become a full orphan drug development company as we continue to rollout novel bio-superior biologic, vaccine and oncology drugs based on our patented technologies.”

"Xenetic Biosciences plc....announces that it has appointed Robert Gagnon as Chief Finance Officer of Xenetic Biosciences Inc., the company's US subsidiary. Robert's extensive background in finance, US financial reporting procedures and capital markets is highly relevant to Xenetic as the Company continues expand its US drug development operations and also as it continues to explore ways to efficiently achieve a possible US listing. It is of particular note that Biogen Idec, a $50 billion market cap company in which Robert amassed such hugely valuable experience, had a powerful focus on discovering, developing, manufacturing and marketing therapies for the treatment of multiple sclerosis (MS) and other autoimmune disorders, a development area in which Xenetic has a particular interest...." http://www.lse.co.uk/share-regulatory-news.asp?shareprice=XEN&ArticleCode=d9yxq4yc&ArticleHeadline=Senior_Appointment_in_Boston_MA

are a crucial step, for several reasons: they are the first time XEN has had a candidate under its own development; they are FDA compliant; it is XEN's intention to licence PSA-EPO out during or after Ph II; there is interest from pharma in doing so; and if that happens, XEN earns not only a fat fee upfront but an very delicious ongoing royalty. That's just one of our fourteen candidates. As Dutch says, all looking good so far.

will be anxious to know my considered opinion on the recent conference call with Mr Maguire: Though I was able to get through at shortly after the scheduled start time (residing as I do at Hacienda Snooty in the Philippines during the summer, and that country not being noted for its excellence in telecommunications) - as I was able to get through, I say, I was finally able to insert a question of some erudition and value amongst the tittle-tattle that had gone before. Unfortunately, a sunspot over Cebu, or some such event, completely garbled my well-chosen words, to the extent that the excellent Mr Maguire though that he was talking to Donald Duck. I await the transcript on the XEN website.